European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol 2015;63(4):971–1004. https://www.ncbi.nlm.nih.gov/pubmed/26341719
Gleeson D, Heneghan MA, British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut 2011;60(12):1611–29. https://www.ncbi.nlm.nih.gov/pubmed/21757447
Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48(1):169–76. https://www.ncbi.nlm.nih.gov/pubmed/18537184
van Gerven NM, Verwer BJ, Witte BI, van Hoek B, Coenraad MJ, van Erpecum KJ, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013;58(1):141–7. https://www.ncbi.nlm.nih.gov/pubmed/22989569
